ReviewDrug design, development and therapy2019

Levonadifloxacin, a Novel Broad-Spectrum Anti-MRSA Benzoquinolizine Quinolone Agent: Review of Current Evidence.

Sachin S Bhagwat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.